(PharmaNewsWire.Com, March 03, 2017 ) Browse 216 market data tables and 47 figures spread through 243 pages and in-depth TOC on “ENT Devices Market - Global Forecast to 2020”
Early buyers will receive 10% customization on reports.
The global ENT Devices market is expected to reach USD 14,001.3 Million by 2020 from USD 10,219.3 Million in 2015, at a CAGR of 6.5% during the forecast period.
The report segments the ENT devices market based on product, end user, and region. On the basis of products, the ENT devices market is segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, CO2 lasers, and image-guided surgery systems. Hearing aids are expected to account for the largest share of ENT devices market, in 2015.
Factors such as high prevalence of chronic sinusitis, rising geriatric population, favorable reimbursement scenario for ENT procedures in developed countries, rising adoption of minimally invasive ENT procedures, increasing presence of prominent players in the ENT devices market, and technological advancements are expected to drive the ENT devices market growth.
Among end users, the ambulatory settings segment is expected to grow at the highest CAGR during the forecast period. On the basis of region, the ENT devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2015. However, the Asian market is expected to grow at the highest CAGR, mainly due to the growing preference for minimally invasive ENT surgeries, rise in disposable incomes in developing countries, rapidly growing elderly population, increase in focus of market players on India, and less stringent regulatory guidelines.
The ENT devices market is highly competitive, with presence of several big as well as emerging market players. In addition, each product segment has a different set of vendors. Key market players include Medtronic plc (Ireland), Olympus Corporation (Japan), Karl STORZ GmbH & Co (Germany), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Acclarent, Inc. (U.S.), Hoya Corporation (Japan), Sonova Holdings AG (Switzerland), William Demant Holdings A/S (Denmark), and Cochlear Limited (Australia).
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
